Strategies to generate high-titer, high-potency recombinant AAV3 serotype vectors

Molecular Therapy Methods and Clinical Development

Volumn 3, Issue , 2016, Pages 16029-

  Ling, Chen ^a,b   Yin, Zifei ^a   Li, Jun ^a   Zhang, Daniel ^a   Aslanidi, George ^a   Srivastava, Arun ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENO ASSOCIATED VIRUS VECTOR; CIS ACTING ELEMENT; DNA HELICASE; SERINE; THREONINE; RECOMBINANT DNA;

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS 3; ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENETIC TRANSDUCTION; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INVERTED TERMINAL REPEAT; LIVER TUMOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; RECOMBINANT PLASMID; SEROTYPE; VIRUS CAPSID; WASTE; HEK293 CELL LINE; LIVER CELL CARCINOMA; PROMOTER REGION; VIRAL GENE THERAPY;

EID: 85015173308     PISSN: None     EISSN: 23290501     Source Type: Journal    
DOI: 10.1038/mtm.2016.29     Document Type: Article

References (45)

1. 1 Ponnazhagan, S, Mukherjee, P, Yoder, MC, Wang, XS, Zhou, SZ, Kaplan, J, et al. Adeno-associated virus 2-mediated gene transfer in vivo: organ-tropism and expression of transduced sequences in mice. Gene 190 (1997), 203–210.
2. 2 Snyder, RO, Miao, CH, Patijn, GA, Spratt, SK, Danos, O, Nagy, D, et al. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Genet 16 (1997), 270–276.
3. 3 Glushakova, LG, Lisankie, MJ, Eruslanov, EB, Ojano-Dirain, C, Zolotukhin, I, Liu, C, et al. AAV3-mediated transfer and expression of the pyruvate dehydrogenase E1 alpha subunit gene causes metabolic remodeling and apoptosis of human liver cancer cells. Mol Genet Metab 98 (2009), 289–299.
4. 4 Ling, C, Lu, Y, Cheng, B, McGoogan, KE, Gee, SW, Ma, W, et al. High-efficiency transduction of liver cancer cells by recombinant adeno-associated virus serotype 3 vectors. J Vis Exp, 49, 2011, Pii 2538, doi:10.3791/2538.
5. 5 Ling, C, Lu, Y, Kalsi, JK, Jayandharan, GR, Li, B, Ma, W, et al. Human hepatocyte growth factor receptor is a cellular coreceptor for adeno-associated virus serotype 3. Hum Gene Ther 21 (2010), 1741–1747.
6. 6 Zhong, L, Li, B, Mah, CS, Govindasamy, L, Agbandje-McKenna, M, Cooper, M, et al. Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses. Proc Natl Acad Sci USA 105 (2008), 7827–7832.
7. 7 Aslanidi, GV, Rivers, AE, Ortiz, L, Song, L, Ling, C, Govindasamy, L, et al. Optimization of the capsid of recombinant adeno-associated virus 2 (AAV2) vectors: the final threshold?. PLoS One, 8, 2013, e59142.
8. 8 Pandya, J, Ortiz, L, Ling, C, Rivers, AE, Aslanidi, G, Rationally designed capsid and transgene cassette of AAV6 vectors for dendritic cell-based cancer immunotherapy. Immunol Cell Biol 92 (2014), 116–123.
9. 9 Cheng, B, Ling, C, Dai, Y, Lu, Y, Glushakova, LG, Gee, SW, et al. Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells. Gene Ther 19 (2012), 375–384.
10. 10 Ling, C, Wang, Y, Zhang, Y, Ejjigani, A, Yin, Z, Lu, Y, et al. Selective in vivo targeting of human liver tumors by optimized AAV3 vectors in a murine xenograft model. Hum Gene Ther 25 (2014), 1023–1034.
11. 11 Li, S, Ling, C, Zhong, L, Li, M, Su, Q, He, R, et al. Efficient and targeted transduction of nonhuman primate liver with systemically delivered optimized AAV3B vectors. Mol Ther 23 (2015), 1867–1876.
12. 12 Lisowski, L, Dane, AP, Chu, K, Zhang, Y, Cunningham, SC, Wilson, EM, et al. Selection and evaluation of clinically relevant AAV variants in a xenograft liver model. Nature 506 (2014), 382–386.
13. 13 Wang, L, Bell, P, Somanathan, S, Wang, Q, He, Z, Yu, H, et al. Comparative study of liver gene transfer with AAV vectors based on natural and engineered AAV capsids. Mol Ther 23 (2015), 1877–1887.
14. 14 Ling, C, Wang, Y, Feng, YL, Zhang, YN, Li, J, Hu, XR, et al. Prevalence of neutralizing antibodies against liver-tropic adeno-associated virus serotype vectors in 100 healthy Chinese and its potential relation to body constitutions. J Integr Med 13 (2015), 341–346.
15. 15 Vercauteren, K, Hoffman, BE, Zolotukhin, I, Keeler, GD, Xiao, JW, Basner-Tschakarjan, E, et al. Superior in vivo transduction of human hepatocytes using engineered AAV3 capsid. Mol. Ther, 2016 Advance online publication 19 April 2016. doi:10.1038/mt.2016.61.
16. 16 Ling, C, Wang, Y, Lu, Y, Wang, L, Jayandharan, GR, Aslanidi, GV, et al. Enhanced transgene expression from recombinant single-stranded D-sequence-substituted adeno-associated virus vectors in human cell lines in vitro and in murine hepatocytes in vivo. J Virol 89 (2015), 952–961.
17. 17 Nathwani, AC, Tuddenham, EG, Rangarajan, S, Rosales, C, McIntosh, J, Linch, DC, et al. Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med 365 (2011), 2357–2365.
18. 18 Zhou, X, Gao, G, Owens, RA, Lu, Y, Calcedo, R, Miller, J, et al. Roles of inverted terminal repeats (ITRs) and capsid proteins from novel NHP AAVs in rAAV mediated gene transfer. Mol Ther, 11, 2005, S156.
19. 19 Grimm, D, Pandey, K, Nakai, H, Storm, TA, Kay, MA, Liver transduction with recombinant adeno-associated virus is primarily restricted by capsid serotype not vector genotype. J Virol 80 (2006), 426–439.
20. 20 Samulski, RJ, Muzyczka, N, AAV-mediated gene therapy for research and therapeutic purposes. Annu Rev Virol 1 (2014), 427–451.
21. 21 Ling, C, Wang, Y, Lu, Y, Wang, L, Jayandharan, GR, Aslanidi, GV, et al. The adeno-associated virus genome packaging puzzle. J Mol Genet Med, 9, 2015, 3 1000178.
22. 22 Wang, L, Yin, Z, Wang, Y, Lu, Y, Zhang, D, Srivastava, A, et al. Productive life cycle of adeno-associated virus serotype 2 in the complete absence of a conventional polyadenylation signal. J Gen Virol 96 (2015), 2780–2787.
23. 23 Zhao, L, Li, W, Zhou, Y, Zhang, Y, Huang, S, Xu, X, et al. The overexpression and nuclear translocation of Trx-1 during hypoxia confers on HepG2 cells resistance to DDP, and GL-V9 reverses the resistance by suppressing the Trx-1/Ref-1 axis. Free Radic Biol Med 82 (2015), 29–41.
24. 24 Grimm, D, Zolotukhin, S, E Pluribus Unum: 50 years of research, millions of viruses, and one goal-tailored acceleration of AAV evolution. Mol Ther 23 (2015), 1819–1831.
25. 25 Wang, Y, Ling, C, Song, L, Wang, L, Aslanidi, GV, Tan, M, et al. Limitations of encapsidation of recombinant self-complementary adeno-associated viral genomes in different serotype capsids and their quantitation. Hum Gene Ther Methods 23 (2012), 225–233.
26. 26 Kapranov, P, Chen, L, Dederich, D, Dong, B, He, J, Steinmann, KE, et al. Native molecular state of adeno-associated viral vectors revealed by single-molecule sequencing. Hum Gene Ther 23 (2012), 46–55.
27. 27 Wu, J, Zhao, W, Zhong, L, Han, Z, Li, B, Ma, W, et al. Self-complementary recombinant adeno-associated viral vectors: packaging capacity and the role of rep proteins in vector purity. Hum Gene Ther 18 (2007), 171–182.
28. 28 Wang, XS, Ponnazhagan, S, Srivastava, A, Rescue and replication signals of the adeno-associated virus 2 genome. J Mol Biol 250 (1995), 573–580.
29. 29 Wang, XS, Ponnazhagan, S, Srivastava, A, Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: selective encapsidation of viral genomes in progeny virions. J Virol 70 (1996), 1668–1677.
30. 30 Wang, XS, Qing, K, Ponnazhagan, S, Srivastava, A, Adeno-associated virus type 2 DNA replication in vivo: mutation analyses of the D sequence in viral inverted terminal repeats. J Virol 71 (1997), 3077–3082.
31. 31 Qing, K, Hansen, J, Weigel-Kelley, KA, Tan, M, Zhou, S, Srivastava, A, Adeno-associated virus type 2-mediated gene transfer: role of cellular FKBP52 protein in transgene expression. J Virol 75 (2001), 8968–8976.
32. 32 Jayandharan, GR, Zhong, L, Li, B, Kachniarz, B, Srivastava, A, Strategies for improving the transduction efficiency of single-stranded adeno-associated virus vectors in vitro and in vivo. Gene Ther 15 (2008), 1287–1293.
33. 33 Ping, H, Liu, X, Zhu, D, Li, T, Zhang, C, Construction and gene expression analysis of a single-stranded DNA minivector based on an inverted terminal repeat of adeno-associated virus. Mol Biotechnol 57 (2015), 382–390.
34. 34 Nault, JC, Datta, S, Imbeaud, S, Franconi, A, Mallet, M, Couchy, G, et al. Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas. Nat Genet 47 (2015), 1187–1193.
35. 35 Berns, KI, Byrne, BJ, Flotte, TR, Gao, G, Hauswirth, WW, Herzog, RW, et al. Adeno-associated virus type 2 and hepatocellular carcinoma?. Hum Gene Ther 26 (2015), 779–781.
36. 36 Büning, H, Schmidt, M, Adeno-associated vector toxicity-to be or not to be?. Mol Ther 23 (2015), 1673–1675.
37. 37 Lin, S, Gregory, RI, Identification of small molecule inhibitors of Zcchc11 TUTase activity. RNA Biol 12 (2015), 792–800.
38. 38 Zhang, YH, Wang, Y, Yusufali, AH, Ashby, F, Zhang, D, Yin, ZF, et al. Cytotoxic genes from traditional Chinese medicine inhibit tumor growth both in vitro and in vivo. J Integr Med 12 (2014), 483–494.
39. 39 Bai, F, Ho Lim, C, Jia, J, Santostefano, K, Simmons, C, Kasahara, H, et al. Directed differentiation of embryonic stem cells into cardiomyocytes by bacterial injection of defined transcription factors. Sci Rep, 5, 2015, 15014.
40. 40 Zhao, L, Miao, HC, Li, WJ, Sun, Y, Huang, SL, Li, ZY, et al. LW-213 induces G2/M cell cycle arrest through AKT/GSK3β/β-catenin signaling pathway in human breast cancer cells. Mol Carcinog, 2015 (epub ahead of print).
41. 41 Lin, S, Shen, H, Li, JL, Tang, S, Gu, Y, Chen, Z, et al. Proteomic and functional analyses reveal the role of chromatin reader SFMBT1 in regulating epigenetic silencing and the myogenic gene program. J Biol Chem 288 (2013), 6238–6247.
42. 42 Hirt, B, Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol 26 (1967), 365–369.
43. 43 Dong, B, Moore, AR, Dai, J, Roberts, S, Chu, K, Kapranov, P, et al. A concept of eliminating nonhomologous recombination for scalable and safe AAV vector generation for human gene therapy. Nucleic Acids Res 41 (2013), 6609–6617.
44. 44 Dong, B, Duan, X, Chow, HY, Chen, L, Lu, H, Wu, W, et al. Proteomics analysis of co-purifying cellular proteins associated with rAAV vectors. PLoS One, 9, 2014, e86453.
45. 45 Wang, Q, Dong, B, Firrman, J, Roberts, S, Moore, AR, Cao, W, et al. Efficient production of dual recombinant adeno-associated viral vectors for factor VIII delivery. Hum Gene Ther Methods 25 (2014), 261–268.